More specifically, a 57.7% and 35.8% inhibition of cancer cell motility was obtained when 200 μg/ml of anti-Cdc37 was included in the culture medium of MDA-MB-453 and MDA-MB-231 cells respectively (Figs. 4C and 5C). The gene discussed is CDC37; the disease is cancer.